{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:01:20Z","timestamp":1776423680598,"version":"3.51.2"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Institute of Health and Society"},{"DOI":"10.13039\/501100020256","name":"Faculty of Medicine, University of Oslo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Despite the high global prevalence of Mycobacterium tuberculosis (Mtb) infection in humans, most infected individuals achieve a stable immunological equilibrium, without showing clinical signs and symptoms of tuberculosis (TB). Although the role of antibodies in TB is assumed to be relatively small compared with cell-mediated immunity, their role in TB has been documented in a few recent studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this cross-sectional study, we quantitated antibody responses to Mtb antigens, lipoarabinomannan (LAM), and heparin-binding hemagglutinin adhesin (HBHA) by determining antigen-specific immunoglobulin A(IgA) and G(IgG) secretion levels using enzyme-linked immunosorbent assay in serum and saliva of pulmonary TB patients (PTB), their household contacts, and community controls (determined by QuantiFERON TB Gold assay QFT-test result).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The HBHA-specific IgA levels were significantly higher in both saliva and serum in household contacts groups compared with PTB patients (P\u2005=\u20050.013, P\u2005=\u20050.023). Exposed contacts, who were QFT-negative, had higher serum HBHA-specific IgA responses compared with PTB patients (P\u2005=\u20050.04). QFT-negative household contacts and QFT-positive community controls showed higher HBHA and lipoarabinomannan-specific IgG responses (P\u2005=\u20050.006, P\u2005=\u20050.002, P\u2005=\u20050.0009, P\u2005=\u20050.006, respectively) than PTB patients. Generally, lipoarabinomannan and HBHA-specific IgA levels were significantly higher in saliva compared with serum (P\u2005&amp;lt;\u20050.0001) in all study groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Overall, the observed higher levels of IgA and IgG in controls, and exposed but QFT-negative contacts suggest a correlation with, and perhaps a role for these antibodies in preventing the development of active TB. The findings highlighted the potential involvement of saliva IgA in the immune response to Mtb, underscoring the relevance of mucosal immunity in TB infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cei\/uxaf001","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T15:18:50Z","timestamp":1739287130000},"source":"Crossref","is-referenced-by-count":1,"title":["The role of IgA and IgG in\n                    <i>Mycobacterium tuberculosis<\/i>\n                    infection: a cross-sectional study in Ethiopia"],"prefix":"10.1093","volume":"220","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2891-3262","authenticated-orcid":false,"given":"Rubiyat E","family":"Islam","sequence":"first","affiliation":[{"name":"Department of Community Medicine, Institute of Health and Society, University of Oslo , Oslo ,","place":["Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meaza","family":"Zewdie","sequence":"additional","affiliation":[{"name":"Armauer Hansen Research Institute , Immunology Directorate, Addis Ababa ,","place":["Ethiopia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Mussa","sequence":"additional","affiliation":[{"name":"Armauer Hansen Research Institute , Immunology Directorate, Addis Ababa ,","place":["Ethiopia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonas","family":"Abebe","sequence":"additional","affiliation":[{"name":"Armauer Hansen Research Institute , Immunology Directorate, Addis Ababa ,","place":["Ethiopia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom H M","family":"Ottenhoff","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Leiden University Medical Center , Leiden ,","place":["The Netherland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kees L M C","family":"Franken","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Leiden University Medical Center , Leiden ,","place":["The Netherland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5494-5275","authenticated-orcid":false,"given":"Liya","family":"Wassie","sequence":"additional","affiliation":[{"name":"Armauer Hansen Research Institute , Immunology Directorate, Addis Ababa ,","place":["Ethiopia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fekadu","family":"Abebe","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Institute of Health and Society, University of Oslo , Oslo ,","place":["Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"2026041706070184700_uxaf001-B1","volume-title":"Global tuberculosis report 2022","author":"World Health Organization","year":"2022"},{"key":"2026041706070184700_uxaf001-B2","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1080\/08830185.2019.1632842","article-title":"Synergy between Th1 and Th2 responses during Mycobacterium tuberculosis infection: a review of current understanding","volume":"38","author":"Abebe","year":"2019","journal-title":"Int Rev Immunol"},{"key":"2026041706070184700_uxaf001-B3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.tube.2016.08.001","article-title":"Antibodies and tuberculosis","volume":"101","author":"Jacobs","year":"2016","journal-title":"Tuberculosis (Edinb)"},{"key":"2026041706070184700_uxaf001-B4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cell.2016.08.072","article-title":"A functional role for antibodies in tuberculosis","volume":"167","author":"Lu","year":"2016","journal-title":"Cell"},{"key":"2026041706070184700_uxaf001-B5","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41577-018-0028-0","article-title":"Antibodies and tuberculosis: finally coming of age?","volume":"18","author":"Li","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"2026041706070184700_uxaf001-B6","doi-asserted-by":"publisher","first-page":"S225","DOI":"10.1093\/cid\/civ614","article-title":"B in TB: B cells as mediators of clinically relevant immune responses in tuberculosis","volume":"61Suppl 3","author":"Rao","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2026041706070184700_uxaf001-B7","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1513\/AnnalsATS.201306-161MG","article-title":"Mucosal immunity and the microbiome","volume":"11","author":"Neish","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"2026041706070184700_uxaf001-B8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jinf.2015.09.040","article-title":"IFN-\u03b3 and IgA against non-methylated heparin-binding hemagglutinin as markers of protective immunity and latent tuberculosis: results of a longitudinal study from an endemic setting","volume":"72","author":"Belay","year":"2016","journal-title":"J Infect"},{"key":"2026041706070184700_uxaf001-B9","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.36295\/asro.2020.23815","article-title":"Synbiotic and nutrients supplement improved of Secretory Immunoglobulin A (sIgA) in treated pulmonary tuberculosis patients","volume":"23","author":"Samsidi","year":"2020","journal-title":"Public Health"},{"issue":"7","key":"2026041706070184700_uxaf001-B10","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41577-019-0261-1","article-title":"Rethinking mucosal antibody responses: IgM, IgG and IgD join IgA","volume":"20","author":"Chen","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"2026041706070184700_uxaf001-B11","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1128\/IAI.74.5.3006-3011.2006","article-title":"The hbhA gene of Mycobacterium tuberculosis is specifically upregulated in the lungs but not in the spleens of aerogenically infected mice","volume":"74","author":"Delogu","year":"2006","journal-title":"Infect Immun"},{"key":"2026041706070184700_uxaf001-B12","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.3389\/fimmu.2019.01968","article-title":"Lipoarabinomannan in active and passive protection against tuberculosis","volume":"10","author":"Correia-Neves","year":"2019","journal-title":"Front Immunol"},{"key":"2026041706070184700_uxaf001-B13","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.4110\/in.2019.19.e24","article-title":"Emerging themes for the role of antibodies in tuberculosis","volume":"19","author":"Tran","year":"2019","journal-title":"Immune Network"},{"key":"2026041706070184700_uxaf001-B14","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/j.1365-2567.2004.01809.x","article-title":"Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs","volume":"111","author":"Williams","year":"2004","journal-title":"Immunology"},{"key":"2026041706070184700_uxaf001-B15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1006\/prep.1999.1162","article-title":"Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent","volume":"18","author":"Franken","year":"2000","journal-title":"Protein Expr Purif"},{"key":"2026041706070184700_uxaf001-B16","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.1073\/pnas.1611776114","article-title":"Latently and uninfected healthcare workers exposed to TB make protective antibodies against Mycobacterium tuberculosis","volume":"114","author":"Li","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026041706070184700_uxaf001-B17","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1086\/520662","article-title":"Evaluation of Mycobacterium tuberculosis--specific antibody responses in populations with different levels of exposure from Tanzania, Ethiopia, Brazil, and Denmark","volume":"45","author":"Hoff","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2026041706070184700_uxaf001-B18","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.3390\/pathogens11111228","article-title":"Mycobacterium tuberculosis transmission in high-incidence settings-new paradigms and insights","volume":"11","author":"Coleman","year":"2022","journal-title":"Pathogens"},{"key":"2026041706070184700_uxaf001-B19","doi-asserted-by":"publisher","first-page":"4351","DOI":"10.3390\/ijms21124351","article-title":"Host immune response and novel diagnostic approach to NTM infections","volume":"21","author":"Abe","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2026041706070184700_uxaf001-B20","doi-asserted-by":"publisher","first-page":"1802302","DOI":"10.1183\/13993003.02302-2018","article-title":"Detection, survival and infectious potential of Mycobacterium tuberculosis in the environment: a review of the evidence and epidemiological implications","volume":"53","author":"Martinez","year":"2019","journal-title":"Eur Respir J"},{"key":"2026041706070184700_uxaf001-B21","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.15252\/emmm.201606330","article-title":"Human isotype-dependent inhibitory antibody responses against Mycobacterium tuberculosis","volume":"8","author":"Zimmermann","year":"2016","journal-title":"EMBO Mol Med"},{"key":"2026041706070184700_uxaf001-B22","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1086\/430930","article-title":"Effector functions of heparin-binding hemagglutinin\u2013specific CD8+ T lymphocytes in latent human tuberculosis","volume":"192","author":"Temmerman","year":"2005","journal-title":"J Infect Dis"},{"key":"2026041706070184700_uxaf001-B23","doi-asserted-by":"publisher","first-page":"e2221186120","DOI":"10.1073\/pnas.2221186120","article-title":"Reevaluating progression and pathways following Mycobacterium tuberculosis infection within the spectrum of tuberculosis","volume":"120","author":"Horton","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026041706070184700_uxaf001-B24","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/imr.12965","article-title":"BCG-induced protection against Mycobacterium tuberculosis infection: evidence, mechanisms, and implications for next-generation vaccines","volume":"301","author":"Foster","year":"2021","journal-title":"Immunol Rev"},{"key":"2026041706070184700_uxaf001-B25","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1093\/infdis\/jiz261","article-title":"Understanding how BCG vaccine protects against mycobacterium tuberculosis infection: lessons from household contact studies","volume":"221","author":"Lalvani","year":"2020","journal-title":"J Infect Dis"},{"key":"2026041706070184700_uxaf001-B26","doi-asserted-by":"publisher","first-page":"210218","DOI":"10.1183\/16000617.0218-2021","article-title":"The role of antibodies in tuberculosis diagnosis, prophylaxis and therapy: a review from the ESGMYC study group","volume":"31","author":"Melkie","year":"2022","journal-title":"Eur Respir Rev"},{"key":"2026041706070184700_uxaf001-B27","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00216-018-1466-z","article-title":"Epitope and affinity determination of recombinant Mycobacterium tuberculosis Ag85B antigen towards anti-Ag85 antibodies using proteolytic affinity-mass spectrometry and biosensor analysis","volume":"411","author":"Rinaldi","year":"2019","journal-title":"Anal Bioanal Chem"},{"key":"2026041706070184700_uxaf001-B28","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s11274-023-03636-x","article-title":"Clinical manifestations and immune response to tuberculosis","volume":"39","author":"Carabal\u00ed-Isajar","year":"2023","journal-title":"World J Microbiol Biotechnol"},{"key":"2026041706070184700_uxaf001-B29","doi-asserted-by":"publisher","first-page":"e00021","DOI":"10.1128\/CMR.00021-18","article-title":"Incipient and subclinical tuberculosis: a clinical review of early stages and progression of infection","volume":"31","author":"Drain","year":"2018","journal-title":"Clin Microbiol Rev"},{"key":"2026041706070184700_uxaf001-B30","doi-asserted-by":"publisher","first-page":"e0190989","DOI":"10.1371\/journal.pone.0190989","article-title":"IgA and IgG against Mycobacterium tuberculosis Rv2031 discriminate between pulmonary tuberculosis patients, Mycobacterium tuberculosis-infected and non-infected individuals","volume":"13","author":"Abebe","year":"2018","journal-title":"PLoS One"},{"key":"2026041706070184700_uxaf001-B31","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1128\/CVI.00103-06","article-title":"Mycobacterium tuberculosis HBHA protein reacts strongly with the serum immunoglobulin M of tuberculosis patients","volume":"13","author":"Shin","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"2026041706070184700_uxaf001-B32","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1093\/infdis\/173.5.1267","article-title":"T lymphocytic and immature macrophage alveolitis in active pulmonary tuberculosis","volume":"173","author":"Schwander","year":"1996","journal-title":"J Infect Dis"},{"key":"2026041706070184700_uxaf001-B33","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1365-2249.2009.03967.x","article-title":"The protective role of antibody responses during Mycobacterium tuberculosis infection","volume":"157","author":"Abebe","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"2026041706070184700_uxaf001-B34","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/1471-2172-14-S1-S3","volume-title":"BMC immunology","author":"Alvarez","year":"2013"},{"key":"2026041706070184700_uxaf001-B35","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.3389\/fimmu.2018.01205","article-title":"Anti-lipoarabinomannan-specific salivary IgA as prognostic marker for leprosy reactions in patients and cellular immunity in contacts","volume":"9","author":"Nahas","year":"2018","journal-title":"Front Immunol"},{"key":"2026041706070184700_uxaf001-B36","doi-asserted-by":"publisher","first-page":"e0276610","DOI":"10.1371\/journal.pone.0276610","article-title":"Distinct and shared B cell responses of tuberculosis patients and their household contacts","volume":"17","author":"Singh","year":"2022","journal-title":"PLoS One"},{"key":"2026041706070184700_uxaf001-B37","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41591-018-0319-9","article-title":"Prevention of tuberculosis infection and disease by local BCG in repeatedly exposed rhesus macaques","volume":"25","author":"Dijkman","year":"2019","journal-title":"Nat Med"},{"key":"2026041706070184700_uxaf001-B38","doi-asserted-by":"publisher","first-page":"791728","DOI":"10.1155\/2012\/791728","article-title":"Roles of mucosal immunity against Mycobacterium tuberculosis infection","volume":"2012","author":"Li","year":"2012","journal-title":"Tuberc Res Treat"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cei\/advance-article-pdf\/doi\/10.1093\/cei\/uxaf001\/61870462\/uxaf001.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/220\/1\/uxaf001\/68104319\/uxaf001.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/220\/1\/uxaf001\/68104319\/uxaf001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T10:07:12Z","timestamp":1776420432000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/doi\/10.1093\/cei\/uxaf001\/8011498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/cei\/uxaf001","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2025,2,13]]},"article-number":"uxaf001"}}